chr6-129475381-G-A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_000426.4(LAMA2):c.7440-9G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000153 in 1,488,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00052 ( 0 hom., cov: 28)
Exomes 𝑓: 0.00011 ( 0 hom. )
Consequence
LAMA2
NM_000426.4 intron
NM_000426.4 intron
Scores
2
Splicing: ADA: 0.00003055
2
Clinical Significance
Conservation
PhyloP100: 0.317
Publications
0 publications found
Genes affected
LAMA2 (HGNC:6482): (laminin subunit alpha 2) Laminin, an extracellular protein, is a major component of the basement membrane. It is thought to mediate the attachment, migration, and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. It is composed of three subunits, alpha, beta, and gamma, which are bound to each other by disulfide bonds into a cross-shaped molecule. This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). Mutations in this gene have been identified as the cause of congenital merosin-deficient muscular dystrophy. Two transcript variants encoding different proteins have been found for this gene. [provided by RefSeq, Jul 2008]
LAMA2 Gene-Disease associations (from GenCC):
- congenital merosin-deficient muscular dystrophy 1AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- LAMA2-related muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy, limb-girdle, autosomal recessive 23Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 6-129475381-G-A is Benign according to our data. Variant chr6-129475381-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 197945.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LAMA2 | ENST00000421865.3 | c.7440-9G>A | intron_variant | Intron 52 of 64 | 5 | NM_000426.4 | ENSP00000400365.2 | |||
| LAMA2 | ENST00000618192.5 | c.7704-9G>A | intron_variant | Intron 53 of 65 | 5 | ENSP00000480802.2 | ||||
| LAMA2 | ENST00000617695.5 | c.7439+2029G>A | intron_variant | Intron 52 of 63 | 5 | ENSP00000481744.2 | ||||
| ENSG00000226149 | ENST00000665046.1 | n.975+27224C>T | intron_variant | Intron 9 of 9 |
Frequencies
GnomAD3 genomes AF: 0.000523 AC: 75AN: 143408Hom.: 0 Cov.: 28 show subpopulations
GnomAD3 genomes
AF:
AC:
75
AN:
143408
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000165 AC: 39AN: 236158 AF XY: 0.000125 show subpopulations
GnomAD2 exomes
AF:
AC:
39
AN:
236158
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000114 AC: 153AN: 1345394Hom.: 0 Cov.: 21 AF XY: 0.000116 AC XY: 78AN XY: 672756 show subpopulations
GnomAD4 exome
AF:
AC:
153
AN:
1345394
Hom.:
Cov.:
21
AF XY:
AC XY:
78
AN XY:
672756
show subpopulations
African (AFR)
AF:
AC:
57
AN:
30986
American (AMR)
AF:
AC:
2
AN:
43610
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
24780
East Asian (EAS)
AF:
AC:
4
AN:
38518
South Asian (SAS)
AF:
AC:
5
AN:
78068
European-Finnish (FIN)
AF:
AC:
3
AN:
47334
Middle Eastern (MID)
AF:
AC:
0
AN:
5498
European-Non Finnish (NFE)
AF:
AC:
72
AN:
1020458
Other (OTH)
AF:
AC:
10
AN:
56142
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000523 AC: 75AN: 143516Hom.: 0 Cov.: 28 AF XY: 0.000490 AC XY: 34AN XY: 69380 show subpopulations
GnomAD4 genome
AF:
AC:
75
AN:
143516
Hom.:
Cov.:
28
AF XY:
AC XY:
34
AN XY:
69380
show subpopulations
African (AFR)
AF:
AC:
68
AN:
38252
American (AMR)
AF:
AC:
0
AN:
14036
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3422
East Asian (EAS)
AF:
AC:
1
AN:
4964
South Asian (SAS)
AF:
AC:
0
AN:
4314
European-Finnish (FIN)
AF:
AC:
0
AN:
9322
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
5
AN:
66086
Other (OTH)
AF:
AC:
1
AN:
1934
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:1
May 20, 2014
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 02, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
LAMA2-related muscular dystrophy Benign:1
Nov 25, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.